Takaisin Tulosta

Nivelreuma, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
29.10.2026

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Nivelreuma «Nivelreuma»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Allaire SH, Li W, LaValley MP. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation: a randomized controlled trial. Arthritis Rheum 2003;48(11):3212-8 «PMID: 14613285»PubMed
  2. Abbott JH, Schmitt J. Minimum important differences for the patient-specific functional scale, 4 region-specific outcome measures, and the numeric pain rating scale. J Orthop Sports Phys Ther 2014;44(8):560-4 «PMID: 24828475»PubMed
  3. Alasaarela E, Takalo R, Tervonen O, ym. Sonography and MRI in the evaluation of painful arthritic shoulder. Br J Rheumatol 1997;36(9):996-1000 «PMID: 9376998»PubMed
  4. Aletaha D, Funovits J, Breedveld FC, ym. Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthritis Rheum 2009;60(5):1242-9 «PMID: 19404938»PubMed
  5. Al-Saoodi H, Kolahdooz F, Andersen JR, ym. Effect of vitamin D on inflammatory and clinical outcomes in patients with rheumatoid arthritis: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Rev 2024;82(5):600-611 «PMID: 37437898»PubMed
  6. Andonian BJ, Ross LM, Sudnick AM, ym. Effect of Remotely Supervised Weight Loss and Exercise Training Versus Lifestyle Counseling on Cardiovascular Risk and Clinical Outcomes in Older Adults With Rheumatoid Arthritis: A Randomized Controlled Trial. ACR Open Rheumatol 2024;6(3):124-136 «PMID: 38126260»PubMed
  7. Angeli A, Guglielmi G, Dovio A, ym. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 2006;39(2):253-9 «PMID: 16574519»PubMed
  8. Arvidsson S, Bergman S, Arvidsson B, ym. Effects of a self-care promoting problem-based learning programme in people with rheumatic diseases: a randomized controlled study. J Adv Nurs 2013;69(7):1500-14 «PMID: 22973890»PubMed
  9. Baillet A, Gaujoux-Viala C, Mouterde G, ym. Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) 2011;50(6):1137-47 «PMID: 21278073»PubMed
  10. Bakker MF, Jacobs JW, Welsing PM, ym. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann Intern Med 2012;156(5):329-39 «PMID: 22393128»PubMed
  11. Behrens F, Koehm M, Schwaneck EC, ym. Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis. BMC Rheumatol 2019;3():51 «PMID: 31867564»PubMed
  12. Bellan M, Andreoli L, Nerviani A, ym. Is cholecalciferol a potential disease-modifying anti-rheumatic drug for the management of rheumatoid arthritis? Clin Exp Rheumatol 2020;38(2):343-349 «PMID: 31573472»PubMed
  13. Bertrand D, Joly J, Neerinckx B, ym. Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial. RMD Open 2024;10(3): «PMID: 39117445»PubMed
  14. Bilberg A, Mannerkorpi K, Borjesson M, ym. High-intensity interval training improves cardiovascular and physical health in patients with rheumatoid arthritis: a multicentre randomised controlled trial. Br J Sports Med 2024;58(23):1409-1418 «PMID: 39179363»PubMed
  15. Boniface G, Gandhi V, Norris M, ym. A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis. Rheumatology (Oxford) 2020;59(11):3147-3157 «PMID: 32780816»PubMed
  16. Bostan ZZ, Şare Bulut M, Özen Ünaldı B, ym. Effect of Plant-Based Diets on Rheumatoid Arthritis: A Systematic Review. Nutr Rev 2025;83(7):e1798-e1814 «PMID: 39786551»PubMed
  17. Bounabe A, Elammare S, Janani S, ym. Effectiveness of patient education on the quality of life of patients with rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2024;69():152569 «PMID: 39423700»PubMed
  18. Breedveld FC, Weisman MH, Kavanaugh AF, ym. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54(1):26-37 «PMID: 16385520»PubMed
  19. Campbell L, Chen C, Bhagat SS, ym. Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatology (Oxford) 2011;50(3):552-62 «PMID: 21078627»PubMed
  20. Cerasola D, Argano C, Chiovaro V, ym. Physical Exercise and Occupational Therapy at Home to Improve the Quality of Life in Subjects Affected by Rheumatoid Arthritis: A Randomized Controlled Trial. Healthcare (Basel) 2023;11(15): «PMID: 37570365»PubMed
  21. Chatzidionysiou K, Lie E, Nasonov E, ym. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis 2011;70(9):1575-80 «PMID: 21571731»PubMed
  22. Claassen S, van Steenbergen HW, van der Helm-van Mil AHM. Assessment of the minimal clinically important difference for the Health Assessment Questionnaire Disability Index in patients with arthralgia at risk for progression to rheumatoid arthritis. RMD Open 2025;11(3): «PMID: 40983396»PubMed
  23. Costenbader KH, Cook NR, Lee IM, ym. Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 2024;76(6):973-983 «PMID: 38272846»PubMed
  24. Courvoisier DS, Chatzidionysiou K, Mongin D, ym. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. Rheumatology (Oxford) 2021;60(2):820-828 «PMID: 32810263»PubMed
  25. de Buck PD, le Cessie S, van den Hout WB, ym. Randomized comparison of a multidisciplinary job-retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss. Arthritis Rheum 2005;53(5):682-90 «PMID: 16208658»PubMed
  26. de Lemos LL, Costa Jde O, Machado MA, ym. Rituximab for rheumatoid arthrits treatment: a systematic review. Rev Bras Reumatol 2014;54(3):220-30 «PMID: 25054600»PubMed
  27. Di Franco M, Barchetta I, Iannuccelli C, ym. Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study. BMC Musculoskelet Disord 2015;16():53 «PMID: 25887374»PubMed
  28. Durcan L, Wilson F, Cunnane G. The effect of exercise on sleep and fatigue in rheumatoid arthritis: a randomized controlled study. J Rheumatol 2014;41(10):1966-73 «PMID: 25128510»PubMed
  29. Fayet F, Pereira B, Fan A, ym. Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study. Rheumatol Int 2021;41(11):2025-2030 «PMID: 34050794»PubMed
  30. Fedorenko E, Lukina GV, Sigidin YA, et al. Remission as the main goal of treatment in early rheumatoid arthritis patients: comparative efficacy of four treatmentregimens. Ann Rheum Dis 2011;70(Suppl 3):598
  31. Feng X, Xu X, Shi Y, ym. Body Mass Index and the Risk of Rheumatoid Arthritis: An Updated Dose-Response Meta-Analysis. Biomed Res Int 2019;2019():3579081 «PMID: 31355257»PubMed
  32. Gaujoux-Viala C, Nam J, Ramiro S, ym. Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2014;73(3):510-5 «PMID: 24395555»PubMed
  33. Genel F, Kale M, Pavlovic N, ym. Health effects of a low-inflammatory diet in adults with arthritis: a systematic review and meta-analysis. J Nutr Sci 2020;9():e37 «PMID: 32983422»PubMed
  34. Giraudet-Le Quintrec JS, Mayoux-Benhamou A, Ravaud P, ym. Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial. J Rheumatol 2007;34(8):1684-91 «PMID: 17610321»PubMed
  35. Grigor C, Capell H, Stirling A, ym. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364(9430):263-9 «PMID: 15262104»PubMed
  36. Grønning K, Rannestad T, Skomsvoll JF, ym. Long-term effects of a nurse-led group and individual patient education programme for patients with chronic inflammatory polyarthritis - a randomised controlled trial. J Clin Nurs 2014;23(7-8):1005-17 «PMID: 23875718»PubMed
  37. Grønning K, Skomsvoll JF, Rannestad T, ym. The effect of an educational programme consisting of group and individual arthritis education for patients with polyarthritis--a randomised controlled trial. Patient Educ Couns 2012;88(1):113-20 «PMID: 22277625»PubMed
  38. Guagnano MT, D'Angelo C, Caniglia D, ym. Improvement of Inflammation and Pain after Three Months' Exclusion Diet in Rheumatoid Arthritis Patients. Nutrients 2021;13(10): «PMID: 34684536»PubMed
  39. Hafström I, Albertsson K, Boonen A, ym. Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann Rheum Dis 2009;68(4):508-13 «PMID: 18420939»PubMed
  40. Hammond A, Freeman K. The long-term outcomes from a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Clin Rehabil 2004;18(5):520-8 «PMID: 15293486»PubMed
  41. Hannonen P, Möttönen T, Hakola M, ym. Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study. Arthritis Rheum 1993;36(11):1501-9 «PMID: 7902092»PubMed
  42. Hetland ML, Heiberg MS, Sokka-Isler T, ym. Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm. Ann Rheum Dis 2025;84(6):937-948 «PMID: 40188008»PubMed
  43. Hetland ML, Stengaard-Pedersen K, Junker P, ym. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008;67(6):815-22 «PMID: 17878209»PubMed
  44. Hetland ML, Stengaard-Pedersen K, Junker P, ym. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006;54(5):1401-9 «PMID: 16645967»PubMed
  45. Hetland ML, Østergaard M, Ejbjerg B, ym. Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP. Ann Rheum Dis 2012;71(6):851-6 «PMID: 22302316»PubMed
  46. Heutz JW, de Jong PHP, Verstappen M, ym. Sustained DMARD-free remission in subgroups of patients with rheumatoid arthritis: an analysis of two prospective cohorts with early arthritis. Lancet Rheumatol 2025;7(4):e252-e260 «PMID: 39718182»PubMed
  47. Hysa E, Gotelli E, Campitiello R, ym. Vitamin D and Muscle Status in Inflammatory and Autoimmune Rheumatic Diseases: An Update. Nutrients 2024;16(14): «PMID: 39064771»PubMed
  48. Häkkinen A, Sokka T, Kautiainen H, ym. Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis: a 5 year follow up. Ann Rheum Dis 2004;63(8):910-6 «PMID: 15249317»PubMed
  49. Hørslev-Petersen K, Hetland ML, Junker P, ym. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Ann Rheum Dis 2014;73(4):654-61 «PMID: 23434570»PubMed
  50. Isaacs JD, Cohen SB, Emery P, ym. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis 2013;72(3):329-36 «PMID: 22689315»PubMed
  51. John H, Hale ED, Treharne GJ, ym. A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. Rheumatology (Oxford) 2013;52(1):81-90 «PMID: 22942402»PubMed
  52. Jones B, Bennett S, Larsson I, ym. Disseminating and assessing implementation of the EULAR recommendations for patient education in inflammatory arthritis: a mixed-methods study with patients' perspectives. RMD Open 2022;8(1): «PMID: 35459751»PubMed
  53. Kerschbaumer A, Sepriano A, Bergstra SA, ym. Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2023;82(1):95-106 «PMID: 36368906»PubMed
  54. Kirwan JR, Hewlett S, Cockshott Z, ym. Clinical and psychological outcomes of patient education in rheumatoid arthritis. Musculoskeletal Care 2005;3(1):1-16 «PMID: 17041989»PubMed
  55. Kjørholt KE, Sundlisæter NP, Aga AB, ym. Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial. Lancet Rheumatol 2024;6(5):e268-e278 «PMID: 38583450»PubMed
  56. Lange E, Kucharski D, Svedlund S, ym. Effects of Aerobic and Resistance Exercise in Older Adults With Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis Care Res (Hoboken) 2019;71(1):61-70 «PMID: 29696812»PubMed
  57. Launois R, Avouac B, Berenbaum F, ym. Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis. J Rheumatol 2011;38(5):835-45 «PMID: 21239748»PubMed
  58. Leirisalo-Repo M, Kautiainen H, Laasonen L, ym. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Ann Rheum Dis 2013;72(6):851-7 «PMID: 22753402»PubMed
  59. Lineker SC, Bell MJ, Wilkins AL, ym. Improvements following short term home based physical therapy are maintained at one year in people with moderate to severe rheumatoid arthritis. J Rheumatol 2001;28(1):165-8 «PMID: 11196519»PubMed
  60. Lopez-Olivo MA, Lin H, Rizvi T, ym. Randomized Controlled Trial of Patient Education Tools for Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2021;73(10):1470-1478 «PMID: 32583971»PubMed
  61. Machold KP, Landewé R, Smolen JS, ym. The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Ann Rheum Dis 2010;69(3):495-502 «PMID: 20223838»PubMed
  62. Maneiro RJ, Salgado E, Carmona L, ym. Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis. Semin Arthritis Rheum 2013;43(1):9-17 «PMID: 23290690»PubMed
  63. Manzo A, Bozzalla Cassione E, Montecucco C, ym. Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study. RMD Open 2025;11(1): «PMID: 39880410»PubMed
  64. Mathieux R, Marotte H, Battistini L, ym. Early occupational therapy programme increases hand grip strength at 3 months: results from a randomised, blind, controlled study in early rheumatoid arthritis. Ann Rheum Dis 2009;68(3):400-3 «PMID: 19015209»PubMed
  65. Maxwell L, Singh JA. Abatacept for rheumatoid arthritis. Cochrane Database Syst Rev 2009;2009(4):CD007277 «PMID: 19821401»PubMed
  66. Mohamed Ahamada M, Wu X. Analysis of efficacy and safety of abatacept for rheumatoid arthritis: systematic review and meta-analysis. Clin Exp Rheumatol 2023;41(9):1882-1900 «PMID: 36912326»PubMed
  67. Montecucco C, Todoerti M, Sakellariou G, ym. Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study. Arthritis Res Ther 2012;14(3):R112 «PMID: 22584017»PubMed
  68. Mäkinen H, Kautiainen H, Hannonen P, ym. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. J Rheumatol 2007;34(2):316-21 «PMID: 17183623»PubMed
  69. Möttönen T, Hannonen P, Leirisalo-Repo M, ym. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353(9164):1568-73 «PMID: 10334255»PubMed
  70. Möttönen TT, Hannonen P, Toivanen J, ym. Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis. Ann Rheum Dis 1988;47(3):183-9 «PMID: 3355257»PubMed
  71. Nagy Z, Szigedi E, Takács S, ym. The Effectiveness of Psychological Interventions for Rheumatoid Arthritis (RA): A Systematic Review and Meta-Analysis. Life (Basel) 2023;13(3): «PMID: 36984004»PubMed
  72. Nakayama Y, Nagata W, Takeuchi Y, ym. Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Mod Rheumatol 2024;34(6):1079-1094 «PMID: 38814660»PubMed
  73. Navarro-Millán I, Singh JA, Curtis JR. Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor. Clin Ther 2012;34(4):788-802.e3 «PMID: 22444783»PubMed
  74. Nelson J, Sjöblom H, Gjertsson I, ym. Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials. Nutrients 2020;12(10): «PMID: 33003645»PubMed
  75. Ohno T, Aune D, Heath AK. Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies. Sci Rep 2020;10(1):16006 «PMID: 32994434»PubMed
  76. Paalanen K, Rannio K, Rannio T, ym. Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study. Clin Exp Rheumatol 2019;37(1):37-43 «PMID: 29998832»PubMed
  77. Paimela L. The radiographic criterion in the 1987 revised criteria for rheumatoid arthritis. Reassessment in a prospective study of early disease. Arthritis Rheum 1992;35(3):255-8 «PMID: 1536665»PubMed
  78. Paul D, Fazeli MS, Mintzer L, ym. Comparative efficacy and safety of current therapies for early rheumatoid arthritis: a systematic literature review and network meta-analysis. Clin Exp Rheumatol 2020;38(5):1008-1015 «PMID: 32301430»PubMed
  79. Pendolino M, Serban T, Ferrari G, ym. STEp-down approach in MEthotrexate use for the Treatment of Rheumatoid Arthritis (STEMETRA): a pilot study demonstrating efficacy and safety of short-term, high dose methotrexate. Clin Exp Rheumatol 2025;43(5):841-846 «PMID: 40153328»PubMed
  80. Peran M, Allado E, Albuisson E, ym. Performance of ultrasound to assess erosion progression in rheumatoid arthritis. Eur J Radiol 2021;136():109536 «PMID: 33465551»PubMed
  81. Puolakka K, Kautiainen H, Möttönen T, ym. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52(1):36-41 «PMID: 15641055»PubMed
  82. Puolakka K, Kautiainen H, Möttönen T, ym. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann Rheum Dis 2005;64(1):130-3 «PMID: 15608311»PubMed
  83. Rantalaiho V, Kautiainen H, Korpela M, ym. Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial. Ann Rheum Dis 2014;73(4):788-90 «PMID: 24297374»PubMed
  84. Rantalaiho VM, Kautiainen H, Korpela M, ym. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial. Ann Rheum Dis 2013;72(5):786-8 «PMID: 23349132»PubMed
  85. Rausch Osthoff AK, Vlieland TPMV, Ferreira RJO, ym. EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 update. Ann Rheum Dis 2026;85(6):1026-1038 «PMID: 42036268»PubMed
  86. Rezaei H, Saevarsdottir S, Forslind K, ym. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial. Ann Rheum Dis 2012;71(2):186-91 «PMID: 21930734»PubMed
  87. Riemsma RP, Taal E, Kirwan JR, ym. Systematic review of rheumatoid arthritis patient education. Arthritis Rheum 2004;51(6):1045-59 «PMID: 15593105»PubMed
  88. Rossini M, Viapiana O, Vitiello M, ym. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 2017;69(1):30-39 «PMID: 28535619»PubMed
  89. Ruiz Garcia V, Burls A, Cabello JB, ym. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database Syst Rev 2017;9(9):CD007649 «PMID: 28884785»PubMed
  90. Scheel AK, Schmidt WA, Hermann KG, ym. Interobserver reliability of rheumatologists performing musculoskeletal ultrasonography: results from a EULAR "Train the trainers" course. Ann Rheum Dis 2005;64(7):1043-9 «PMID: 15640263»PubMed
  91. Schipper LG, Fransen J, den Broeder AA, ym. Time to achieve remission determines time to be in remission. Arthritis Res Ther 2010;12(3):R97 «PMID: 20487520»PubMed
  92. Schoels MM, van der Heijde D, Breedveld FC, ym. Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement. Ann Rheum Dis 2013;72(4):583-9 «PMID: 23144446»PubMed
  93. Schönenberger KA, Schüpfer AC, Gloy VL, ym. Effect of Anti-Inflammatory Diets on Pain in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Nutrients 2021;13(12): «PMID: 34959772»PubMed
  94. Scirè CA, Lunt M, Marshall T, ym. Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis 2014;73(9):1677-82 «PMID: 23749581»PubMed
  95. Scirè CA, Verstappen SM, Mirjafari H, ym. Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2011;63(7):945-52 «PMID: 21337726»PubMed
  96. Sepriano A, Kerschbaumer A, Bergstra SA, ym. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2023;82(1):107-118 «PMID: 36376026»PubMed
  97. Sieczkowska SM, Smaira FI, Mazzolani BC, ym. Efficacy of home-based physical activity interventions in patients with autoimmune rheumatic diseases: A systematic review and meta-analysis. Semin Arthritis Rheum 2021;51(3):576-587 «PMID: 33945907»PubMed
  98. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev 2010;(7):CD008331 «PMID: 20614469»PubMed
  99. Singh JA, Christensen R, Wells GA, ym. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev 2009;2009(4):CD007848 «PMID: 19821440»PubMed
  100. Singh JA, Noorbaloochi S, Singh G. Golimumab for rheumatoid arthritis: a systematic review. J Rheumatol 2010;37(6):1096-104 «PMID: 20436075»PubMed
  101. Smolen JS, Landewé RBM, Bergstra SA, ym. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2023;82(1):3-18 «PMID: 36357155»PubMed
  102. Smolen JS, Landewé RBM, Bijlsma JWJ, ym. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 2020;79(6):685-699 «PMID: 31969328»PubMed
  103. Sobue Y, Kojima T, Ito H, ym. Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthritis. Mod Rheumatol 2022;32(1):96-104 «PMID: 33565350»PubMed
  104. Soen S, Kaku M, Okubo N, ym. Fracture risk associated with glucocorticoid-induced osteoporosis in Japan. J Bone Miner Metab 2022;40(4):636-647 «PMID: 35546370»PubMed
  105. Soini I, Kotaniemi A, Kautiainen H, ym. US assessment of hip joint synovitis in rheumatic diseases. A comparison with MR imaging. Acta Radiol 2003;44(1):72-8 «PMID: 12631003»PubMed
  106. Stavropoulos-Kalinoglou A, Metsios GS, Veldhuijzen van Zanten JJ, ym. Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis 2013;72(11):1819-25 «PMID: 23155222»PubMed
  107. Svensson B, Andersson ML, Bala SV, ym. Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria. BMJ Open 2013;3(9):e003554 «PMID: 24022393»PubMed
  108. Szkudlarek M, Narvestad E, Klarlund M, ym. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum 2004;50(7):2103-12 «PMID: 15248207»PubMed
  109. Tarp S, Furst DE, Dossing A, ym. Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials. Semin Arthritis Rheum 2017;46(6):699-708 «PMID: 27769592»PubMed
  110. Ten Klooster PM, Oude Voshaar MAH, Fakhouri W, ym. Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy. Clin Rheumatol 2019;38(10):2727-2736 «PMID: 31161488»PubMed
  111. Teuwen MMH, van Weely SFE, Vliet Vlieland TPM, ym. Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial. Ann Rheum Dis 2024;83(4):437-445 «PMID: 38171602»PubMed
  112. Tiippana-Kinnunen T, Laasonen L, Kautiainen H, ym. Impact of early radiographic remission on the 15-year radiographic outcome in patients with rheumatoid arthritis. Scand J Rheumatol 2011;40(4):263-8 «PMID: 21417549»PubMed
  113. Todoerti M, Scirè CA, Boffini N, ym. Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis. Ann N Y Acad Sci 2010;1193():139-45 «PMID: 20398020»PubMed
  114. Vadell AKE, Bärebring L, Hulander E, ym. Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity. Am J Clin Nutr 2020;111(6):1203-1213 «PMID: 32055820»PubMed
  115. van der Heijde DM, van Riel PL, Nuver-Zwart IH, ym. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1(8646):1036-8 «PMID: 2565997»PubMed
  116. van Nies JA, van der Helm-van Mil AH. Is early remission associated with improved survival or is arthritis persistency associated with increased mortality in early arthritis? Comparisons with the general population. Ann Rheum Dis 2013;72(11):e25 «PMID: 23852696»PubMed
  117. van Vollenhoven R, Takeuchi T, Pangan AL, ym. Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled Trial. Arthritis Rheumatol 2020;72(10):1607-1620 «PMID: 32638504»PubMed
  118. van Vollenhoven RF, Ernestam S, Geborek P, ym. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet 2009;374(9688):459-66 «PMID: 19665644»PubMed
  119. Verstappen SM, van Albada-Kuipers GA, Bijlsma JW, ym. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Ann Rheum Dis 2005;64(1):38-43 «PMID: 15130899»PubMed
  120. Ward MM, Leigh JP, Fries JF. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Arch Intern Med 1993;153(19):2229-37 «PMID: 8215726»PubMed
  121. Ward MM. Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis. J Rheumatol 1997;24(1):35-42 «PMID: 9002008»PubMed
  122. Wassenberg S, Rau R, Zeidler H, ym. A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial. Clin Exp Rheumatol 2011;29(5 Suppl 68):S68-72 «PMID: 22018187»PubMed
  123. Wen Z, Chai Y. Effectiveness of resistance exercises in the treatment of rheumatoid arthritis: A meta-analysis. Medicine (Baltimore) 2021;100(13):e25019 «PMID: 33787585»PubMed
  124. Wu Z, Zhu Y, Wang Y, ym. The Effects of Patient Education on Psychological Status and Clinical Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Front Psychiatry 2022;13():848427 «PMID: 35370836»PubMed
  125. Ye H, Weng H, Xu Y, ym. Effectiveness and safety of aerobic exercise for rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. BMC Sports Sci Med Rehabil 2022;14(1):17 «PMID: 35123568»PubMed
  126. Østergaard M, van Vollenhoven RF, Rudin A, ym. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial. Ann Rheum Dis 2023;82(10):1286-1295 «PMID: 37423647»PubMed
Artikkelin tunnus: nix03895 (021.010)
© 2026 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit